Loading page…
Vilin Bio Med Limited is listed on the NSE. Auto-imported from the exchange master list; profile pending.
Beta is measured against NIFTY 50 over three years of weekly returns — 1 moves with the index, above 1 amplifies it, below 1 damps it.
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Corporate actions, results dates and filings will appear here once ingested.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
Standalone figures
| Ratio | Mar 2025 | Mar 2026 |
|---|---|---|
| Margins | ||
| Gross margin % | 9% | 11% |
| EBITDA margin % | 5.3% | 7.6% |
| EBIT margin % | 4.7% | 6.9% |
| PAT margin % | 1.5% | 4.6% |
| Working capital | ||
| Receivable days | — | — |
| Inventory days | 119 | 70 |
| Payable days | — | — |
| NWC days | — | — |
| Leverage | ||
| Current ratio | 2.75 | 4.25 |
| Debt to EBITDA | — | — |
| Debt to equity | — | — |
| Interest coverage | 1.4 | 41.6 |
| Asset turnover | 0.53 | 1.21 |
| Return ratios | ||
| Return on assets % | 0.8% | 5.5% |
| Return on capital employed % | 5% | 11.3% |
| Return on equity % | — | — |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Anawil Wire And Engineering LimitedANAWILANAWIL | ₹1,064 Cr | — | — | — | — | — | — | — | — | — |
| Credent Connect N Care LimitedCREDENTCREDENT | ₹696 Cr | — | — | — | — | — | — | — | — | — |
| Metalic Technoforge LimitedMETALICMETALIC | ₹426 Cr | — | — | — | — | — | — | — | — | — |
| Optimystix Entertainment India LimitedOPTIMYSTIXOPTIMYSTIX | ₹307 Cr | — | — | — | — | — | — | — | — | — |
| Pramodini Medicare LimitedPRAMODINIPRAMODINI | ₹254 Cr | ₹271 Cr | ₹62 Cr | — | — | ₹17 Cr | 27.9% | -11.3% | 39.1% | — |
| Annapurna Swadisht LimitedANNAPURNAANNAPURNA | ₹211 Cr | — | ₹520 Cr | ₹72 Cr | 13.9% | ₹32 Cr | 6.2% | — | — | — |
| Fascinate Textiles LimitedFASCINATEFASCINATE | ₹102 Cr | — | — | — | — | — | — | — | — | — |
| Propshop Events And Exhibitions LimitedPROPSHOPPROPSHOP | ₹97 Cr | — | ₹70 Cr | ₹11 Cr | 15.8% | ₹8 Cr | 11.4% | — | — | — |
| Vinod Texworld LimitedVINODVINOD | ₹82 Cr | — | — | — | — | — | — | — | — | — |
| Skytech Infinite Platform LimitedSKYTECHSKYTECH | ₹38 Cr | ₹44 Cr | — | — | — | — | — | — | — | — |
| Dhansa Labs LimitedDHANSADHANSA | — | — | ₹142 Cr | ₹11 Cr | 7.7% | ₹6 Cr | 3.9% | — | — | — |
| Divine Power Energy LimitedDPELDPEL | — | — | ₹626 Cr | ₹51 Cr | 8.1% | ₹27 Cr | 4.3% | — | — | — |
No scheme among the 32 fund houses on record reported a position in Vilin Bio Med Limited. Portfolios are published monthly by each AMC; coverage is still partial.
Quarterly shareholding records haven't been ingested for this company.
Annual reports, earnings call transcripts and presentations will appear here once ingested.
| ₹ Cr | Mar 2025 | Mar 2026 |
|---|---|---|
| 15 | 42 | |
| COGS | 13 | 38 |
| Gross profit | 1 | 5 |
| 1 | 1 | |
| Operating profit (EBITDA) | 1 | 3 |
| OPM % | 5.3% | 7.6% |
| Depreciation | 0 | 0 |
| Interest | 1 | 0 |
| 0 | 0 | |
| Profit before tax | 0 | 3 |
| Tax | 0 | 1 |
| Tax % | 25.8% | 32% |
| 0 | 2 | |
| PAT margin % | 1.5% | 4.6% |
| EPS (₹) | 0.2 | 1.4 |
| ₹ Cr | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity capital | — | — |
| Reserves | — | — |
| Borrowings | — | — |
| 28 | 35 | |
| Total equity & liabilities | 28 | 35 |
| Fixed assets | 1 | 3 |
| CWIP | — | — |
| Investments | 0 | 0 |
| 26 | 32 | |
| Total assets | 28 | 35 |
| ₹ Cr | Mar 2025 | Mar 2026 |
|---|---|---|
| -4 | 1 | |
| -1 | -0 | |
| -1 | 1 | |
| Net cash flow | -6 | 1 |
| Free cash flow | -5 | 0 |
| CFO / Operating profit % | -484.8% | 21.9% |